Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01841931Phase 4Terminated

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Role: lead

NCT06752759Phase 3Recruiting

Nebulized Ketamine for the Treatment of Major Depressive Disorder

Role: lead

NCT05615948Phase 4Completed

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Role: lead

All 3 trials loaded